Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.